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Difficulties of Using Single-Diseased Guidelines to Treat Patients
with Multiple Diseases
Discipline- and disease-specific medical care is increasingly underpinned by evidence-based guide-
lines. The main goal of these guidelines is to give the best available diagnostic and treatment advice,
to decrease variability in daily clinical practice, to reduce inappropriate practice, and to improve
cost-effectiveness, ideally resulting in better health outcomes for patients (1). For example, the Royal
Dutch Society for Physical Therapy (KNGF) and the Dutch College of General Practitioners (NHG)
have published 17 and 96 disease-specific guidelines, respectively, all with the aim of providing a
stronger scientific foundation and improve health care (2, 3). However, themajority of patients [40%
at the age of 50 years and at least two-thirds of the octogenarian population (4)] simultaneously suffer
from multiple medical problems. Caregivers, therefore, need to consider single-disease evidence
contained in a guideline in the view of other relevant guidelines. In this matter, Hurwitz et al.
(5) already warned that guidelines may encourage users to apply recommendations “rigidly or
unthinkingly,” even in situations where departure from a guideline would be desirable, as might
be the case with multimorbidity. Thus, when treating multi-diseased patients, physical therapists
(PT) themselves have to design a customized treatment plan based on guidelines developed for
patients with only one disease and in consideration of the impact of multimorbidity. Once a patient
with multimorbidity is admitted to a physical therapy practice, the therapist may consider multiple
treatment paths. This situation could be compared with a maze: a complex branching passage with
many different pathways. To solve the maze, the PT must find a route to travel from start to finish.
The Maze of Multimorbidity
The maze of multimorbidity could be entered at different points based on the disease (e.g., type,
severity) and the health needs for which the patient has been referred to the PT.
Imagine that a patient with intermittent claudication [IC: a symptom of symptomatic Peripheral
Arterial Disease (sPAD); see vignette in Figure 1] was not referred to the PT for the treatment of
sPAD, but by a pulmonologist for the treatment of chronic obstructive pulmonary disease (COPD).
Consequently, the treatment focus would not be aimed at increasing themaximumwalking distance,
but instead at reducing dyspnea and improving mucus clearance.
Abbreviations: COPD, chronic obstructive pulmonary disease; IC, intermittent claudication; PT, physical therapist; Spad,
symptomatic peripheral arterial disease.
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FIGURE 1 | The maze of multimorbidity.
The maze of multimorbidity also has different final and inter-
mediate exit points (i.e., desired treatment outcomes). The final
outcome is set by the disease for which the patient was referred.
For example, if a patient with sPAD visits the PT with the aim to
increase the maximum walking distance, the desirable outcome
of physical therapy treatment could be an increase in meters that
the patient can walk. Imagine that this patient would be hindered
while walking by shortness of breath due to COPD. Then, the
intermediate goal for physical therapy care would be an improve-
ment in breathing techniques. After the breathing problems have
been reduced, the PT may continue treating the index disease
sPAD. If the PT continues treating the patient without taking heed
of the observed shortness of breath, the patientwill never reach the
desired treatment outcome. The patient will always be hindered at
the same point because he or she is walking into a dead end due
to limitations related to COPD.
Experience-Based Evidence: A Solution in
Cases of Multimorbidity?
The maze metaphor illustrates that clinical decisions in physical
therapy require considering a discrete range of choices fromwhich
the PT will select the most appropriate treatment or intervention
to meet a patient’s specific needs. Ideally, we make these choices
based on the highest value of level 1a evidence from research.
However, complex patients suffering from multimorbidity are
under-represented in systematic reviews and randomized con-
trolled trials (RCTs) because their presence presents method-
ological challenges (6). Hence, collecting evidence on all possible
disease combinations might even be an impossible endeavor. The
high level of heterogeneity in the study population would require
researchers to recruit impossibly large study populations. Taking
into account loss to follow-up and drop-out rates, required sample
sizes will enlarge.
How to proceed from here? Relying on experience-based evi-
dence might be an option, to underpin current practice. For
example, Moitra et al. (8) elaborated on the impossibility to per-
form large epidemiological studies in case of perioperative cardiac
arrest, a disease that occurs rarely, has a heterogeneous spectrum
of causes and is distinct from cardiac arrest in other settings. The
authors highlighted that from a practical point of view, it is not
feasible to avoid anesthesia during surgical manipulation in order
to be able to investigate the contribution of anesthesia to cardiac
arrest. However, among anesthesiologists, there is much exper-
tise and experience in managing cardiac arrest in perioperative
patients and thus experience-based evidence should be cherished
in the generation of protocols. But, relying on care providers,
experience has also raised discussion in many different fields in
medicine (8–10). Rinchuse et al. (7), for instance, from the field of
Orthodontic and Dentofacial Orthopedics, warn for incautiously
trusting personal perceptions (empiricism), highly respected peo-
ple (authority), intuitively appealing logical ideas (rationalism),
and longheld beliefs (tenacity). Although these pitfalls exist, Leape
et al. (9) from the field of Health Policy and Management stated
that there will never be complete evidence for everything, but that
the alternative is to make reasonable judgments based on best
available evidence in combination with successful experiences in
health care.
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Acknowledging the pitfalls of experience-based information,
it may be helpful when large numbers of data are collected and
analyzed in a systematic way. In general, identifying the specific
influence of comorbidities on treatment outcome, in addition
to considering PTs’ experiences working with these patients in
the past, may enable us to identify possible alternations of treat-
ment for these patient groups and therefore improve treatment
success. Health professionals gradually acquire experiences that
enable them to make implicit connections between patients who
need to be treated and patients they have seen in the past. In
the context of systematically gathered experience-based evidence,
curve matching may be a powerful approach that can enhance the
memory of health professionals by putting existing information
(i.e., electronic medical record data collections) to a new use. The
key idea is to find relevant historic data about patients who are
similar to the new patient and to use this data to suggest the
treatment outcome of the new patient (6, 11). This approach takes
into account the uniqueness of patients by including individual
patient characteristics and specific disease combinations in the
treatment outcome determination. It gives PTs the opportunity
to customize medical treatments for individual patients. Hence,
putting existing information to a new and systematic usemay help
guide PT through the complex process of managing patients with
multimorbidity.
Author Contributions
All authors contributed to his work. The ideas of the manuscript
were discussed with the whole project team. SD, IM, and RB
wrote the manuscript. JT commented on the manuscript and gave
conceptual advice at the final stage.
Acknowledgments
Funding: This study was made possible by a NWO Graduate
Programme grant (grant number 022.003.036).
References
1. Woolf SH, Grol R, HutchinsonA, EcclesM, Grimshaw J, et al. Potential benefits,
limitations, and harms of clinical guidelines. BMJ (1999) 318:527–30. doi:10.
1136/bmj.318.7182.527
2. Van der Wees PJ, Hendriks EJM, Veldhuizen RJ. Quality assurance in the
Netherlands: from development to implementation and evaluation. Centre
for Evidence Based Physiotherapy (2003). Available from: http://www.cebp.nl/
media/m38.pdf
3. Braspenning J, Schellevis F, Grol R. Tweede Nationale Studie Naar Ziekten en
Verrichtingen in deHuisartsenpraktijk. Kwaliteit Huisartsenzorg Belicht. Utrecht:
NIVEL (2004).
4. Ornstein SM, Nietert PJ, Jenkins RG, Litvin CB. The prevalence of chronic
diseases and multimorbidity in primary care practice: a PPRNet report. J Am
Board Fam Med (2013) 26:518–24. doi:10.3122/jabfm.2013.05.130012
5. Hurwitz B. Legal and political considerations of clinical practice guidelines.BMJ
(1999) 318:661–4. doi:10.1136/bmj.318.7184.661
6. Hardy SE, Allore H, Studenski SA. Missing data: a special challenge in aging
research. J Am Geriatr Soc (2009) 57:722–9. doi:10.1111/j.1532-5415.2008.
02168.x
7. Rinchuse DJ, Rinchuse DJ, Kandasamy S. Evidence-based versus experience-
based views on occlusion and TMD. Am J Orthod Dentofacial Orthop (2005)
127:249–54. doi:10.1016/j.ajodo.2004.02.012
8. Moitra VK, Gabrielli A, Maccioli AG, et al. Anesthesia advanced
circulatory life support. Can J Anesth (2012) 59(6):586–603. doi:10.1007/
s12630-012-9699-3
9. Leape LL, Berwick DM, Bates DW. What practices will most improve safety?
Evidence-based medicine meets patient safety. JAMA (2002) 288:501–7. doi:10.
1001/jama.288.4.501
10. Hay MC,Weisner TS, Subramanian S, Duan N, Niedzinski EJ, Kravitz RL. Har-
nessing experience: exploring the gap between evidence-based medicine and
clinical practice. J Eval Clin Pract (2008) 14:707–13. doi:10.1111/j.1365-2753.
2008.01009.x
11. Van Buuren S. Curve matching: a data-driven technique to improve individ-
ual prediction of childhood growth. Ann Nutr Metab (2014) 65(2–3):227–33.
doi:10.1159/000365398
Conflict of Interest Statement:We declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest. Thismanuscript has not been previously published and
is not under consideration in the same or substantially similar form in any other
peer-reviewed media. We declare that we have no significant competing financial,
professional, or personal interests that might have influenced the performance
or presentation of the work described in this manuscript. All authors listed have
contributed sufficiently to the project to be included as authors.
Copyright © 2015 Dörenkamp, Mesters, Teijink and de Bie. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC
BY). The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Public Health | www.frontiersin.org April 2015 | Volume 3 | Article 673
